Cancer Vaccine Institute News

Last week, KING 5 News featured ongoing research at the Cancer Vaccine Institute (CVI) to develop COLOVAC , a preventive vaccine designed to stop colon cancer before it starts. The segment included interviews with CVI Director Dr. Nora Disis and Becky Bruhn, a Seattle resident whose recent cancerous polyp illustrates the importance of early detection and need for new prevention tools. Colon cancer remains one of the leading causes of cancer death in the United States, and rat

Photos from the October 23rd event include: Dr. Nora Disis (CVI Director), Dr. Robert Jones (University of Washington President), Dr. Lynn Hassan Jones, Dr. Tim Dellit (UW Medicine CEO), Jean Enersen (Former KING5 News Anchor), Pramila Jayapal (US House of Representatives), Susan Bevan (CVI Development Council Member) October was a powerful month at the University of Washington, as Husky Athletics partnered with the Huskies for a Cure  campaign to raise awareness and funds f

Last week at the Cancer Vaccine Institute, we witnessed a moment of joy, pride, and profound recognition as Dr. Nora Disis was honored as a Delta Community Captain . In a surprise event filled with CVI lab members, Seahawks representatives, Delta Air Lines team members, and Dr. Disis’ family, the room erupted in celebration of a scientist whose work is transforming the future of breast cancer care. The Delta Community Captain program, powered by Delta Air Lines in partnership

Developing Vaccines to Create a New Standard of Care On October 22, 2025, the Cancer Vaccine Institute (CVI) at UW Medicine welcomed patients, advocates, researchers, and community members to DeLille Cellars in Woodinville, WA for an evening of connection and discovery. “Changing the Course of Ovarian Cancer” highlighted how cancer vaccines, once considered aspirational, are now changing lives and redefining what’s possible in cancer care. Driving a New Standard of Care The e

We are thrilled to announce that Dr. Natasha Hunter, MD, has been appointed Director of Clinical Trials at the Cancer Vaccine Institute (CVI). Dr. Hunter is a translational breast cancer researcher and clinical oncologist at the University of Washington and Fred Hutchinson Cancer Center. Her research focuses on circulating tumor DNA to guide treatment decisions and monitor disease response, as well as immunologic strategies to detect micrometastatic disease and prevent cancer